BRPI0817522A2 - Método otimizado e definido de isolamento e preservação de células precursoras a partir do cordão umbilical humano - Google Patents

Método otimizado e definido de isolamento e preservação de células precursoras a partir do cordão umbilical humano

Info

Publication number
BRPI0817522A2
BRPI0817522A2 BRPI0817522-5A2A BRPI0817522A BRPI0817522A2 BR PI0817522 A2 BRPI0817522 A2 BR PI0817522A2 BR PI0817522 A BRPI0817522 A BR PI0817522A BR PI0817522 A2 BRPI0817522 A2 BR PI0817522A2
Authority
BR
Brazil
Prior art keywords
precursing
preserving
optimized
insulating
cells
Prior art date
Application number
BRPI0817522-5A2A
Other languages
English (en)
Portuguese (pt)
Inventor
Rita Isabel Ganchas Soares
Jorge Miguel Silva Santos
Jose Paulo Martins
Vera Alexandra Basto
Pedro Estilita Monteiro Da Cruz
Helder Joaquim Soares Da Cruz
Original Assignee
Medinfar Produtos Farmaceuticos S A Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medinfar Produtos Farmaceuticos S A Lab filed Critical Medinfar Produtos Farmaceuticos S A Lab
Publication of BRPI0817522A2 publication Critical patent/BRPI0817522A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
BRPI0817522-5A2A 2007-10-04 2008-10-03 Método otimizado e definido de isolamento e preservação de células precursoras a partir do cordão umbilical humano BRPI0817522A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PT103843A PT103843B (pt) 2007-10-04 2007-10-04 Método de isolamento de células precursoras a partir do cordão umbilical humano
PCT/IB2008/054067 WO2009044379A2 (en) 2007-10-04 2008-10-03 Optimised and defined method for isolation and preservation of precursor cells from human umbilical cord

Publications (1)

Publication Number Publication Date
BRPI0817522A2 true BRPI0817522A2 (pt) 2014-10-14

Family

ID=40456372

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0817522-5A2A BRPI0817522A2 (pt) 2007-10-04 2008-10-03 Método otimizado e definido de isolamento e preservação de células precursoras a partir do cordão umbilical humano

Country Status (15)

Country Link
US (1) US9546353B2 (enExample)
EP (1) EP2203555B1 (enExample)
JP (1) JP5785394B2 (enExample)
KR (1) KR20100087705A (enExample)
CN (1) CN101868536B (enExample)
AU (1) AU2008306442B2 (enExample)
BR (1) BRPI0817522A2 (enExample)
CA (1) CA2701907A1 (enExample)
EA (1) EA025532B1 (enExample)
ES (1) ES2582369T3 (enExample)
IL (1) IL204788A (enExample)
MX (1) MX2010003511A (enExample)
PT (1) PT103843B (enExample)
WO (1) WO2009044379A2 (enExample)
ZA (1) ZA201002260B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011153205A1 (en) 2010-06-01 2011-12-08 Auxocell Laboratories, Inc. Native wharton's jelly stem cells and their purification
SG189414A1 (en) 2010-10-18 2013-05-31 Sunshine Biotech Inc Human multipotent embryonic stem cell-like progenitor cells
TWI535377B (zh) * 2011-09-01 2016-06-01 Storage, culture and application of umbilical cord tissue and its derived cells
PL3321355T3 (pl) 2011-12-30 2021-12-27 Amit Patel Sposoby i kompozycje do klinicznego pozyskiwania komórek alogenicznych oraz zastosowania terapeutyczne
CN102550543B (zh) * 2012-02-10 2014-04-16 四川新生命干细胞科技股份有限公司 用于保存脐带组织的液体
CN103461322B (zh) * 2012-06-07 2016-08-03 西比曼生物科技（上海）有限公司 用于冻存复苏后的细胞的保存液
EP2756754B1 (de) 2013-01-17 2017-01-04 Vita 34 Ag Verfahren zur Behandlung von Nabelschnurgewebe, insbesondere im Zusammenhang mit der Konservierung des Gewebes
EP3149157A4 (en) * 2014-05-24 2018-06-13 Neelamkrishnan Venkataramanaa A method for targettingglioblastoma with wharton jelly-mesenchymal stem cells (wj-msc) derived from human umbilical cord
CN107073044A (zh) * 2014-11-05 2017-08-18 组织技术公司 用于促进神经生长及再生的组合物和方法
WO2017004460A1 (en) * 2015-06-30 2017-01-05 Surgenex, LLC Compositions and methods for flowable allograft tissue
US11254915B2 (en) * 2015-12-11 2022-02-22 Lei Guo Method for separating and culturing mesenchymal stem cells from Wharton's jelly tissue of umbilical cord
WO2019175773A1 (en) 2018-03-12 2019-09-19 Universidade Do Porto Compositions for use in the treatment of musculoskeletal conditions and methods for producing the same leveraging the synergistic activity of two different types of mesenchymal stromal/stem cells
CN112342191A (zh) * 2019-08-07 2021-02-09 路春光 hMSC生产试剂盒开发和质量管理标准优化和体系建立
CN111893092A (zh) * 2020-06-28 2020-11-06 国大生命科学产业集团(深圳)有限公司 一种人脐带来源的间充质干细胞及其制备方法
CN113025567A (zh) * 2021-03-31 2021-06-25 中国人民解放军陆军特色医学中心 一种椎间盘单细胞的分离方法
DE102021116694B4 (de) * 2021-06-29 2023-03-09 Promocell Gmbh Wässrige Lösung zur Zellkonservierung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT402890B (de) * 1994-03-16 1997-09-25 Berbi Gmbh Verwendung von notoginsenosid r1 zur herstellung von arzneimitteln
AU2003221173A1 (en) * 2002-03-27 2003-10-08 Asahi Kasei Kabushiki Kaisha Placenta-origin mesenchymal cells and medicinal use thereof
AU2006332680A1 (en) * 2005-12-29 2007-07-12 Anthrogenesis Corporation Improved composition for collecting and preserving placental stem cells and methods of using the composition
ES2524443T3 (es) * 2006-11-13 2014-12-09 DePuy Synthes Products, LLC Expansión in vitro de células postparto usando microportadores

Also Published As

Publication number Publication date
EA025532B1 (ru) 2017-01-30
US9546353B2 (en) 2017-01-17
JP2010539970A (ja) 2010-12-24
KR20100087705A (ko) 2010-08-05
PT103843B (pt) 2008-08-12
MX2010003511A (es) 2010-09-10
CA2701907A1 (en) 2009-04-09
IL204788A (en) 2013-07-31
JP5785394B2 (ja) 2015-09-30
US20100216237A1 (en) 2010-08-26
ZA201002260B (en) 2011-06-29
WO2009044379A2 (en) 2009-04-09
CN101868536A (zh) 2010-10-20
EP2203555A2 (en) 2010-07-07
AU2008306442A1 (en) 2009-04-09
ES2582369T3 (es) 2016-09-12
CN101868536B (zh) 2015-03-25
EP2203555B1 (en) 2016-04-13
PT103843A (pt) 2008-01-09
WO2009044379A3 (en) 2009-05-22
IL204788A0 (en) 2010-12-30
AU2008306442B2 (en) 2014-12-04
EA201000425A1 (ru) 2010-10-29

Similar Documents

Publication Publication Date Title
EP2124771A4 (en) DEVICES AND METHODS FOR EXTRACORPORAL ABLATION OF CIRCULATING CELLS
PT2379087E (pt) Células derivadas do tecido do cordão umbilical para o tratamento da dor neuropática e espasticidade
EP2203186A4 (en) REPAIR AND REGENERATION OF KIDNEY TISSUE WITH CELLS FROM HUMAN NAIL CORD
FI20075654A0 (fi) Energiansiirtojärjestely ja -menetelmä
EP2378947A4 (en) METHODS AND DEVICES FOR ENDOSCOPIC ACCESS TO THE HEART
GB2450754B8 (en) Geothermal energy system and method of operation
GB2450755B (en) Geothermal energy system and method of operation
PL2343362T3 (pl) Udoskonalony sposób hodowania komórek
ZA201002260B (en) Optimised and defined method for isolation and preservation of precursor cells from human umbilical cord
GB0823074D0 (en) Design and method of assembly of cdi cells
BRPI0812509A2 (pt) Aparelho reformador e método
EP2054993A4 (en) HYBRID POWER AND METHOD THEREFOR
ZA200905626B (en) Adjuvants and methods of using them
FI20095736A7 (fi) Tehonsiirtomenetelmä ja -laitteisto
EP2280680A4 (en) METHODS AND DEVICES FOR DISSOLVING TISSUE
PT2306865T (pt) Unhas artificiais flexíveis e método de formação das mesmas
EP2222838A4 (en) PROCESS FOR THE EFFECTIVE EXTRACTION OF PROTEIN FROM CELLS
GB2475433B (en) Downhole power generator and method
IL208406A0 (en) Treatment of brain damage damage using umbilical cord cells
DK2118546T3 (da) Holder til kabelstige og fremgangsmåde til fremstilling deraf
EP2145952A4 (en) PROCESS FOR THE REMOVAL OF BIOLOGICAL TISSUE
GB201002469D0 (en) Parthenote-derived stem cells and methods of making and using them
EP2164494A4 (en) Methods of Treatment
PL2179206T3 (pl) Sposób obciążania rur z tworzywa sztucznego
GB201116991D0 (en) Geothermal energy and method of operation

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements
B350 Update of information on the portal [chapter 15.35 patent gazette]